Interim analysis of a phase iii randomized, double-blind studyof vorinostat or placebo combined with bortezomib in relapsedmultple myeloma — Sundar Jagannath (2010) | RDL Network
Interim analysis of a phase iii randomized, double-blind studyof vorinostat or placebo combined with bortezomib in relapsedmultple myeloma
Article 2010 en
Authors
SJ
Sundar Jagannath
DS
DS Siegel
RH
Roman Hájek
Abstract
1 min read
This is a large international randomized trial that has passed
the initial safety evaluations by DMC and is accruing patients
rapidly all over the world. Updated safety data and enrollment
status from the second DMC meeting held in April 2010 will be
presented.
David S. Siegel, Sundar Jagannath, Roman Hájek, Meletios A Dimopoulos, Sung‐Soo Yoon, Sagar Lonial, Jacob P. Laubach, Thorsten Graef, Dina Pietrangelo, Lisa Lupinacci, David Reiser, Kenneth C. Anderson
Sundar Jagannath, D. S. Siegel, Roman Hájek, Meletios A Dimopoulos, Sae Saem Yoon, Sagar Lonial, Thorsten Graef, Lisa Lupinacci, David Reiser, K. C. Anderson
Meletios A Dimopoulos, Xavier Leleu, Jeffrey Matous, David MacDonald, Judith Trotman, Albert Oriol, Chaim Shustik, Alessandra Tedeschi, Ramón García‐Sánz, Leonard T. Heffner, Shuo Ma, Beatrice Mahé, Constantine S. Tam, Olivier Tournilhac, Jianling Li, Priyanka Singh, Elizabeth Bilotti, Thorsten Graef, Steven P. Treon, Christian Buske
María‐Victoria Mateos, Philippe Moreau, Meletios A Dimopoulos, Wan‐Jen Hong, Scott Cooper, Yao Yu, Muhammad Jalaluddin, Jeremy A. Ross, Sudeep Karve, Sheryl Coppola, Paulo Maciag, Orlando F. Bueno, Emma Arriola, Shaji Kumar
Discussion(0)
No comments yet. Be the first to comment.